Palmeri et al. suggested that HER2 overexpression increases metastatic outgrowth of breast cancer cells in the brain [10], and that HER2 overexpression might be a predictor of asymptomatic, occult brain cancer. This evidence concerns the gene ERBB2 and breast carcinoma.